BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Bio NC

  Intuitive Surgical, Inc. Release: Three-Year Outcomes For The Multidisciplinary Convergent Procedure In The Treatment Of Persistent Atrial Fibrillation - New Data Presented At Atrial Fibrillation Symposium

  January 9, 2014

   · 

  1 min read
• Drug Development

  First Patient In Cohort 4 Receives Infusion Of Senesco Technologies, Inc.’s Therapeutic Candidate, SNS01-T, For The Treatment Of Multiple Myeloma And Non-Hodgkins Lymphoma In Phase 1b/2a Clinical Trial

  January 9, 2014

   · 

  1 min read
• Biotech Bay

  SciClone Pharmaceuticals, Inc. Provides 2013 Financial Update And 2014 Guidance

  January 9, 2014

   · 

  5 min read
• FDA

  Direct Flow Medical, Inc. Receives CE Mark For First Fully Repositionable 29 mm Transcatheter Aortic Valve System

  January 9, 2014

   · 

  1 min read
• Drug Development

  Positive Feedback From The Scientific Community For Anaconda Pharma’s Phase 2a Data For AP611074 First Clinical Proof Of Concept For The Curative Treatment Of Condyloma

  January 9, 2014

   · 

  3 min read
• Business

  MiniVax And University of Rochester Enter Into Option For Antibody Treatment Against Pneumocystis Pneumonia

  January 9, 2014

   · 

  1 min read
• BioMidwest

  Athersys, Inc. CEO Gil Van Bokkelen To Be Interviewed On Clear Channel Business Talk Radio DFW 1190AM

  January 9, 2014

   · 

  2 min read
• Business

  Curetis And Laboratorios LETI Sign Exclusive Distribution Agreement For Unyvero™ In Spain And Portugal

  January 9, 2014

   · 

  4 min read
• 2nd Annual Congress Of The European Society For Translational Medicine & Global Network Conference On Translational Medicine (EUSTM-2014)

  January 9, 2014

   · 

  2 min read
• Drug Development

  Neurovance Says Interim Data From Phase 2a Pilot Study Of EB-1020 SR Shows Stimulant-Like Efficacy, But With Lower Risk Of Abuse, For Adult ADHD

  January 9, 2014

   · 

  1 min read